⌘K

Login Start Free

Home/Filings/4/0000950170-25-105128

4//SEC Filing

Harris Todd 4

Accession 0000950170-25-105128

CIK 0001863127other

View on SEC.gov Company Profile

Filed

Aug 6, 8:00 PM ET

Accepted

Aug 7, 4:36 PM ET

Size

5.2 KB

Accession

0000950170-25-105128

Insider Transaction Report

Form 4

Period: 2025-08-07

Tyra Biosciences, Inc.TYRA

DirectorPresident and CEO

Transactions

Award
Stock Option (Right to Buy)
2025-08-07+570,000→ 570,000 total
Exercise: $10.75Exp: 2035-08-06→ Common Stock (570,000 underlying)

Footnotes (1)

[F1]1/48th of the shares subject to the option vest monthly following August 7, 2025, the vesting commencement date, subject to the Reporting Person's continuous service to the Issuer through each vesting date.

Documents

1 file

4
ownership.xmlPrimary
4

Issuer

Tyra Biosciences, Inc.

CIK 0001863127

Entity typeother

Related Parties

1

filerCIK 0001711463

Filing Metadata

Form type: 4
Filed: Aug 6, 8:00 PM ET
Accepted: Aug 7, 4:36 PM ET
Size: 5.2 KB

View on SEC.gov